← SynDRA
LAROPIPRANT
SynDRA canonical compound SYN0006503 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PTGDR |
|---|
| Mechanism of action | Prostanoid receptor antagonist |
|---|
| Indication | cholesterol |
|---|
| Disease area | cardiology |
|---|
All known targets
- PTGDR
- PTGDR2
- PTGER2
- PTGFR
- PTGIR
- TBXA2R
- PTGER1
- PTGER3
- HMGCR
Mechanisms of action (all sources)
- Prostanoid receptor antagonist
- PTGDR ANTAGONIST
- Prostanoid DP receptor antagonist
- HMGCR INHIBITOR
- TBXA2R INHIBITOR
- PTGDR INHIBITOR
- PTGIR INHIBITOR
- PTGDR2 INHIBITOR
- PTGFR INHIBITOR
- PTGER2 INHIBITOR
Cross-references
Synonyms
- MK-0524
- Cordaptive
- Cardaptive
- UNII-G7N11T8O78
- CHEMBL426559
- G7N11T8O78
- 2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid
- 2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methanesulfonyl-1H,2H,3H,4H-cyclopenta[b]indol-3-yl]acetic acid
- Tedaptive
- Laropiprant [USAN:INN:BAN]
- [14C]-Laropiprant
- Laropiprant/MK-0524
- Laropiprant (INN/USAN)
- Laropiprant (MK-0524)
- SCHEMBL991107
- AMOT0189
- GTPL3356
- KS-00000XIE
- CTK8F0660
- MK-0524B
- MK 0524
- MK0524
- laropiprantum
- RefChem:798524
- DTXCID90128247
- C21H19ClFNO4S
- Laropiprant [USAN]
- MFCD11042421
- LAROPIPRANT [MI]
- LAROPIPRANT [INN]
- Laropiprant; MK-0524
- LAROPIPRANT [MART.]
- LAROPIPRANT [WHO-DD]
- orb154710
- LAROPIPRANT [EMA EPAR]
- orb1308138
- SCHEMBL29612617
Look up LAROPIPRANT in the interactive SynDRA portal →